Among these lncRNAs, MALAT1 has been suggested to play an important role in oxymatrine resistance in CRC and has the potential to be a therapeutic target and prognosis biomarker for CRC patients [54, 55]. This evidence concerns the gene MALAT1 and colorectal carcinoma.